Inventor · disambiguated record
Ian Egle
Also filed as: EGLE IAN · EGLE IAN R
13 granted patents·11 pending applications·174 citations·filing 1998–2011
91Inventor score
Top patents by PatentIndex Score
24 records- 0196US7112595B2Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2003·Granted Sep 26, 2006·92 cites·23 claims
- 0293US7485722B2Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2007·Granted Feb 3, 2009·29 cites·13 claims
- 0388US7799792B2Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841ASTRAZENECA AB·Filed 2008·Granted Sep 21, 2010·11 cites·14 claims
- 0486US7868008B2Substituted isoindolones and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2006·Granted Jan 11, 2011·11 cites·4 claims
- 0582US7807706B2Metabotropic glutamate-receptor-potentiating isoindolonesASTRAZENECA AB·Filed 2006·Granted Oct 5, 2010·6 cites·9 claims
- 0681US8377940B2Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842ASTRAZENECA AB·Filed 2008·Granted Feb 19, 2013·4 cites·13 claims
- 0781US7968570B2Isoindolone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2005·Granted Jun 28, 2011·6 cites·4 claims
- 0868US6667336B2GlyT-1 inhibitorsNPS ALLELIX CORP·Filed 2002·Granted Dec 23, 2003·4 cites·66 claims
- 0965US5914401AMethods for the manufacture of quinolone carboxylic acids derivatives and intermediates thereofAPOTEX INC·Filed 1998·Granted Jun 22, 1999·11 cites·16 claims
- 1062US8377939B2Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842ASTRAZENECA AB·Filed 2008·Granted Feb 19, 2013·0 cites·4 claims
- 1160US7790717B2Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2009·Granted Sep 7, 2010·0 cites·2 claims
- 1257US2010280082A1Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as PotentiatorsASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1352US2007032469A1Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulatorsNPS PHARMA INC·Filed 2006·Application pending·0 cites
- 1452US2008318999A1Tricyclic Benzimidazoles and Their Use as Metabotropic Glutamate Receptor ModulatorsISAAC METHVIN·Filed 2006·Application pending·0 cites
- 1547US2011053953A1AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613SLASSI ABDELMALIK·Filed 2008·Application pending·0 cites
- 1645US7816354B2Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2006·Granted Oct 19, 2010·0 cites·6 claims
- 1745US2009149505A1Metabotropic Glutamate Receptor-Potentiating IsoindolonesASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1845US2006189661A1Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsWAGENEN BRADFORD V·Filed 2006·Application pending·0 cites
- 1943US2011166155A1Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor PotentiatorsVAN WAGENEN BRADFORD·Filed 2011·Application pending·0 cites
- 2042US2007021606A1Therapeutic compoundsEGLE IAN·Filed 2004·Application pending·0 cites
- 2141US2009192169A1Bicyclic Benzimidazole Compounds and Their Use as Metabotropic Glutamate Receptor PotentiatorsEGLE IAN·Filed 2007·Application pending·0 cites
- 2240US2009069340A1Pyrazolone Compounds As Metabotropic Glutamate Receptor Agonists For The Treatment Of Neurological And Psychiatric DisordersASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2337US8153638B2Metabotropic glutamate-receptor-potentiating isoindolonesVAN WAGENEN BRADFORD·Filed 2010·Granted Apr 10, 2012·0 cites·3 claims
- 2433US2003176461A1AminopiperidinesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ian Egle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →